During the past decade, ARS Clinical Trials conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "ARS Clinical Trials" #1 collaborator was "Norgine" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "ARS Clinical Trials" are "Gastrointestinal Dysmotility" (2 trials). Many other conditions were trialed in "ARS Clinical Trials" in a lesser frequency.

Most popular intervention types in "ARS Clinical Trials" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "5% dextrose in water" (2 trials), "Ulimorelin Intravenously (IV)" (2 trials) and "Ulimorelin Invtravenously (IV)" (1 trials). Other intervention names were less common.

The vast majority of trials in "ARS Clinical Trials" are 2 trials for "All" genders.

Currently, there are NaN active trials in "ARS Clinical Trials". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in ARS Clinical Trials, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in ARS Clinical Trials, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".